Status:
COMPLETED
Nutrition in Gastrointestinal Tumors
Lead Sponsor:
University Medicine Greifswald
Conditions:
Pancreatic Cancer
Oesophageal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Malnutrition and loss of muscle mass frequently occur in patients undergoing chemotherapy and can negatively effect therapy outcome. Especially patients with cancer of the gastrointestinal tract are o...
Detailed Description
Malnutrition and sarcopenia are common complications in patients with malignant diseases of the gastrointestinal tract. During chemotherapy there is a high risk of further impairment of nutritional st...
Eligibility Criteria
Inclusion
- Patients with initial diagnosis of a malignant condition of the gastrointestinal tract planned to receive cytostatic treatment.
- ongoing cytostatic treatment of a known malignant condition of the gastrointestinal tract
Exclusion
- pregnancy
- history of any other malignant tumor disease
- inability to provide consent
Key Trial Info
Start Date :
June 25 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 6 2022
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT04476082
Start Date
June 25 2020
End Date
December 6 2022
Last Update
January 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medicine Greifswald
Greifswald, Germany, 17475